Thomas Scarborough, MD
Allergy & Immunology · Billings, MTNPI 1235194200
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 35.1% of the total. Reporting peaked in 2021 at $661 and has fallen 64.9% since, to $232 in 2025.
Across 182 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Sanofi$432
- Pfizer$364
- Regeneron Healthcare Solutions, Inc.$262
- CSL Behring$183
- GSK$159
- plus $761 from 15 others
What the payments were for
- Food & beverage$3,28299%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 58 | $1,169 |
| Sanofi | 24 | $432 |
| Pfizer | 25 | $364 |
| Regeneron Healthcare Solutions, Inc. | 14 | $262 |
| CSL Behring | 9 | $183 |
| GSK | 10 | $159 |
| Pharming Healthcare, Inc. | 7 | $110 |
| Amgen(2 entities) | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Blueprint Medicines Corporation | 4 | $87 |
| Biocryst US Sales Co., LLC | 4 | $69 |
| Genentech USA, Inc. | 3 | $51 |
| Grifols USA, LLC | 3 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| Octapharma USA, Inc. | 1 | $30 |
| Novartis | 1 | $28 |
| Shire North American Group Inc | 2 | $26 |
| USWM, LLC | 1 | $24 |
| Kaleo, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $17 |
How this compares
Too few allergy & immunology providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 23 | $86,998 |
| XolairOmalizumab | 20 | $75,978 |
| Spiriva RespimatTiotropium Bromide | 107 | $63,729 |
| Fasenra PenBenralizumab | 11 | $61,092 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $58,641 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $23,602 |
| SymbicortBudesonide/Formoterol Fumarate | 67 | $20,629 |
| DuleraMometasone/Formoterol | 44 | $16,325 |
| Advair HfaFluticasone Propion/Salmeterol | 19 | $10,265 |
| Arnuity ElliptaFluticasone Furoate | 40 | $10,196 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 41 | $6,644 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 28 | $5,491 |
| Cromolyn Sodium | 29 | $5,274 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 148 | $4,835 |
| Pulmicort FlexhalerBudesonide | 12 | $3,380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $159 | $92,439156 claims |
| AstraZenecaSymbicort, Pulmicort Flexhaler | $1,169 | $24,00879 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy & immunology providers in Montanaon file to place this against a meaningful peer group, so we don't.
Other allergy & immunology in Billings
- Juan AdamsBillings$2K
- Kathleen DavisBillings$18
- Carl ThornbladeMissoula$26K
- Michael DicelloBozeman$11K
- Michael ZacharisenBozeman$5K
- Elaine BarbieriGreat Falls$2K
- Summer MonforteHelena$441
- Alan WandererBozeman$194
- Carol CadyMissoula$96
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.